MGI Tech Co News

News

0

Ticker

688114.SS

ISIN

CNE100005PC8

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

MGI Tech Co Eulerpool News

12/9/2024, 2:49:45 PM

Ungewisse Zukunft des BIOSECURE Acts: Ein Schlag für Chinas Biotech-Industrie

Uncertain Future of the BIOSECURE Act: A Blow to China's Biotech Industry

12/9/2024, 2:55:52 AM

Aufatmen bei WuXi: Aktienkurse steigen nach Entlastung durch US-Gesetzesentwurf

Relief at WuXi: Stock Prices Rise Following US Bill Proposal

9/9/2024, 11:54:19 PM

US-Repräsentantenhaus verabschiedet Gesetz zur Einschränkung von Geschäften mit chinesischen Biotech-Firmen

US House of Representatives Passes Law to Restrict Trade with Chinese Biotech Firms

MGI Tech Co Stock News

MGI Tech Co is being monitored by journalists and investors worldwide. We gather the latest MGI Tech Co news here.

MGI Tech Co Stock Press Releases

MGI Tech Co regularly publishes news on the company's website that are relevant for investors.

MGI Tech Co News 2026

This page contains all current news, analysis and press releases for MGI Tech Co stock (688114.SS, ISIN: CNE100005PC8). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at MGI Tech Co.

MGI Tech Co Stock

MGI Tech Co MGI Tech Co Ltd, based in Shenzhen, China, operates in the Health Care sector, specifically within Life Sciences Tools & Services. The company develops and sells DNA sequencing instruments, reagents, and related products for life science research, agriculture, precision medicine, and healthcare. With 2,805 employees, MGI Tech focuses on three core businesses: gene sequencers, laboratory automation systems, and emerging solutions like cytomic technology and bioinformatics. Listed on 9 September 2022, it serves global markets from its Shenzhen headquarters.